0.011

- (-%)
Range 0.011 - 0.011   (-%)
Open 0.011
Previous Close 0.011
Buy Price -
Buy Volume -
Sell Price -
Sell Volume -
Volume 257
Value -
Remark
Measurement Type Value
EPS (USD) -1.933
Trailing EPS (USD) -1.438
NAV (USD) -0.423
Cash In Hand (USD) 0.004
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV -2.888
Price / Cash In Hand 329.73
Issued & Paid-up Shares 11,485,000
Treasury Shares -
Market Cap (M) 14.012
Par Value (USD) n.a.
Beta - 75 Days -0.274
R-Squared - 75 Days(%) 0.12
Beta - 500 Days 0.544
R-Squared - 500 Days(%) 0.71
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 21 Sep 2020 23:10.
Data powered by
View All Events

About ECHO THERAPEUTICS INC

Echo Therapeutics, Inc. (Echo) is a transdermal medical device company. The Company is developing Prelude SkinPrep System (Prelude) as a technology to allow for painless and skin permeation that enable both analyte extraction and needle-free drug delivery. The Company is developing its Symphony CGM System (Symphony) as a non-invasive, wireless continuous glucose monitoring (CGM) system for use in hospital critical care units and for people with diabetes. The Prelude SkinPrep System (Prelude), a component of its Symphony CGM System, allows for skin permeation that enables extraction of analytes such as glucose. Prelude�s platform skin preparation technology also allows for needle-free, transdermal drug delivery.

Loading Chart...